Qube Research & Technologies (QRT)’s Alignment Healthcare ALHC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.7M	Buy	1,517,992 +4,140	+0.3%	+$83.1K	0.03%	710
2025 Q4	$29.9M	Buy	1,513,852 +552,958	+58%	+$9.93M	0.03%	716
2025 Q3	$16.8M	Sell	960,894 -563,092	-37%	-$8.35M	0.02%	993
2025 Q2	$21.3M	Buy	1,523,986 +1,111,685	+270%	+$17.9M	0.02%	843
2025 Q1	$7.68M	Buy	412,301 +343,808	+502%	+$5.13M	0.01%	1291
2024 Q4	$771K	Buy	+68,493	New	+$801K	﹤0.01%	2308
2023 Q3	–	Sell	-21,717	Closed	-$125K	–	4067
2023 Q2	$125K	Sell	21,717 -945	-4%	-$6.11K	﹤0.01%	1907
2023 Q1	$144K	Sell	22,662 -96,790	-81%	-$923K	﹤0.01%	2033
2022 Q4	$1.4M	Buy	119,452 +40,940	+52%	+$498K	0.01%	1070
2022 Q3	$930K	Buy	+78,512	New	+$1.15M	0.01%	1232

Other funds holding ALHC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ALHC Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Alignment Healthcare (ALHC) stake by 0.27% in Q1 2026, buying an estimated $83.1K and bringing the position to 1,517,992 shares worth $26.7M. The position accounts for 0.03% of the portfolio, ranked #710.

Qube Research & Technologies (QRT) first reported a position in ALHC in Q3 2022 and has held it in 10 quarters since. The position peaked at $29.9M in Q4 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

Qube Research & Technologies (QRT) held 1,517,992 shares of Alignment Healthcare worth $26.7M as of Q1 2026.
Qube Research & Technologies (QRT) bought 4,140 Alignment Healthcare shares in Q1 2026, an estimated $83.1K.
Alignment Healthcare made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #710 holding.
Qube Research & Technologies (QRT) first reported a position in Alignment Healthcare in Q3 2022 and has held it in 10 quarters since.
Qube Research & Technologies (QRT)'s Alignment Healthcare position peaked at $29.9M in Q4 2025.
293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.